A quantum chemical and chemometrical study of indolo[2,1-b]quinazoline and their analogues with cytotoxic activity against breast cancer cells

SAR and QSAR in Environmental Research

Volumn 20, Issue 5-6, 2009, Pages 537-549

  Camargo, L T F M ^a   Sena, M M ^a   Camargo, A J ^a  

^a UNIVERSIDADE ESTADUAL DE GOIÁS   (Brazil)

Author keywords

Anticancer activity; PCA; PLS DA; Structure activity relationship; Tryptanthrin

Indexed keywords

CANCER CELLS; CELL CULTURE; CELLS; CYTOTOXICITY; DISEASES; LEAST SQUARES APPROXIMATIONS; MOLECULAR ORBITALS; PRINCIPAL COMPONENT ANALYSIS;

ANTICANCER ACTIVITIES; CYTOTOXIC ACTIVITIES; DESCRIPTORS; DISCRIMINANT MODELS; PCA; PLS-DA; QUANTUM CHEMICAL; QUINAZOLINES; STRUCTURE-ACTIVITY RELATIONSHIPS; TRYPTANTHRIN;

DENSITY FUNCTIONAL THEORY;

EID: 70649086121     PISSN: 1062936X     EISSN: 1029046X     Source Type: Journal    
DOI: 10.1080/10629360903278800     Document Type: Article

References (34)

1. World Health Organization, Cancer, Fact sheet N̊ 297,2007.
2. Reuters, http://www.reuters.com/article/healthNews/idUSN1633064920071217; accessed March 2009.
3. World Health Organization, New Guide on Palliative Care Services for People Living with Advanced Cancer, WHO publications, Geneva, 2007.
4. INCA, http://www.inca.gov.br/estimativa/2008/; accessed March 2009.
5. World Health Organization, World Cancer Report, P. Boyle and B. Levin, eds., International Agency for Research on Cancer, WHO publications, Geneva, 2008.
6. V.F.S. Pinho and E.S.F. Coutinho, Risk factors for breast cancer: a systematic review of studies with female samples among the general population in Brazil, Cad. Saúde Pública 21 (2005), pp. 351-360.
7. V.M. Sharma, P. Prasanna, K.V.A. Seshu, B. Renuka, C.V.L. Rao, G.S. Kumar, C.P. Narasimhulu, P.A. Babu, R.C. Puranik, D. Subramanyam, A. Venkateswarlu, S. Rajagopal, K.B.S. Kumar, C.S. Rao, N.V.S.R. Mamidi, D.S. Deevi, R. Ajaykumar, and R. Rajagopalan, Novel indolo[2,1-b]quinazoline analogues as cytostatic agents: synthesis, biological evaluation and structure-activity relationship, Bioorg. Med. Chem. Lett. 12 (2002), pp. 2303-2307.
8. S.T. Yu, T.M. Chen, S.Y. Tseng, and Y.H. Chen, Tryptanthrin inhibits MDR1 and reverses doxorubicin resistance in breast cancer cells, Biochem. Biophys. Res. Commun. 358 (2007), pp. 79-84.
9. C.W. Jao, W.C. Lin, Y.T. Wu, and P.L. Wu, Isolation, structure elucidation, and synthesis of cytotoxic tryptanthrin analogues from Phaius mishmensis, J. Nat. Prod. 71 (2008), pp. 1275-1279.
10. J.J.P. Stewart, Optimization of parameters for semiempirical methods. 1. Method, J. Comp. Chem. 10 (1989), pp. 209-220.
11. J.J.P. Stewart, Optimization of parameters for semiempirical methods. 2. Applications, J. Comp. Chem. 10 (1989), pp. 221-264.
12. Hyperchem, Release 7.0, Hypercube Inc., Gainesville, FL, 2001.
13. C. Lee, W. Yang, and R.G. Parr, Development of the Colle-Salvetti correlation-energy formula into a functional of the electron-density, Phys. Rev. B 37 (1988), pp. 785-789.
14. A.D. Becke, Density-functional exchange-energy approximation with correct symptotic-behavior, Phys. Rev. A 38 (1988), pp. 3098-3100.
15. M.J. Frisch, G.W. Trucks, H.B. Schlegel, G.E. Scuseria, M.A. Robb, J.R. Cheeseman, J.A. Montgomery Jr, T. Vreven, K.N. Kudin, J.C. Burant, J.M. Millam, S.S. Iyengar, J. Tomasi, V. Barone, B. Mennucci, M. Cossi, G. Scalmani, N. Rega, G.A. Petersson, H. Nakatsuji, M. Hada, M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O. Kitao, H. Nakai, M. Klene, X. Li, J.E. Knox, H.P. Hratchian, J.B. Cross, V. Bakken, C. Adamo, J. Jaramillo, R. Gomperts, R.E. Stratmann, O. Yazyev, A.J. Austin, R. Cammi, C. Pomelli, J.W. Ochterski, P.Y. Ayala, K. Morokuma, G.A. Voth, P. Salvador, J.J. Dannenberg, V.G. Zakrzewski, S. Dapprich, A.D. Daniels, M.C. Strain, O. Farkas, D.K. Malick, A.D. Rabuck, K. Raghavachari, J.B. Foresman, J.V. Ortiz, Q. Cui, A.G. Baboul, S. Clifford, J. Cioslowski, B.B. Stefanov, G. Liu, A. Liashenko, P. Piskorz, I. Komaromi, R.L. Martin, D.J. Fox, T. Keith, M.A. Al-Laham, C.Y. Peng, A. Nanayakkara, M. Challacombe, P.M.W. Gill, B. Johnson, W. Chen, M.W. Wong, C. Gonzalez, and J.A. Pople, Gaussian 03, Revision B.04. Gaussian, Inc., Pittsburgh, PA, 2003.
16. NBO version 3.1, E.D. Glendening, J.E. Carpenter, F. Weinhold. For a description of this program see: E.D. Glendening, A.E. Reed, J.E. Carpenter, and F. Weinhold, NBO 3.0 Program Manual, QCPE Program N° 504.
17. C.M. Breneman and K.W. Wiberg, Determining atom-centered monopoles from molecular electrostatic potentials - The need for high sampling density in formamide conformational analysis, J. Comp. Chem. 11 (1990), pp. 361-373.
18. M.A. Sharaf, D.L. Illman, and B.R. Kolwalski, Chemometrics, Wiley, New York, 1986.
19. R.G. Brereton, Chemometrics: Data Analysis for the Laboratory and Chemical Plant, Wiley, Chichester, 2003.
20. R.G. Brereton, Introduction to multivariate calibration in analytical chemistry, Analyst 125 (2000), pp. 2125-2154.
21. A. Evers, G. Hessler, H. Matter, and T. Klabunde, Virtual screening of biogenic amine-binding G-protein coupled receptors: comparative evaluation of protein- and ligand-based virtual screening protocols, J. Med. Chem. 48 (2005), pp. 5448-5465.
22. C. Carlsson, M. Harju, F. Bahrami, T. Cantillana, M. Tysklind, and I. Brandt, Olfactory mucosal toxicity screening and multivariate QSAR modeling for chlorinated benzene derivatives, Arch. Toxicol. 78 (2004), p. 706.
23. R.W. Kennard and L.A. Stone, Computer aided design of experiments, Technometrics 11 (1969), pp. 137-148.
24. S. Wold, Validation of QSAR's, Quant. Struct. Act. Relat. 10 (1991), pp. 191-193.
25. H. van derVoet, Comparing the predictive accuracy of models using a simple randomization test, Chemometr. Intell. Lab. Syst. 25 (1994), pp. 313-323.
26. TM, Eigenvector Research, Inc., Manson, WA, 1998.
27. J. Lameira, I.G. Medeiros, M. Reis, A.S. Santos, and C.N. Alves, Structure-activity relationship study of flavone compounds with anti-HIV-1 integrase activity: A density functional theory study, Bioorg. Med. Chem. Lett. 14 (2006), pp. 7105-7112.
28. J. Souza Jr, R.H.A. Santos, M.M.C. Ferreira, F.A. Molfetta, A.J. Camargo, K.M. Honório, and A.B.F. Silva, A quantum chemical and statistical study of flavonoid compounds (flavones) with anti-HIV activity, Eur. J. Med. Chem. 38 (2003), pp. 929-938.
29. A.J. Camargo, K.M. Honório, R. Mercadante, F.A. Molfetta, C.N. Alves, and A.B.F. Silva, A study of neolignan compounds with biological activity against Paracoccidioides brasiliensis by using quantum chemical and chemometric methods, J. Braz. Chem. Soc. 14 (2003), pp. 809-814.
30. C.N. Alves, J.C. Pinheiro, A.J. Camargo, A.J. de Souza, R.B. Carvalho, and A.B.F. da Silva, A quantum chemical and statistical study of flavonoid compounds with anti-HIV activity, J. Mol. Struct. (THEOCHEM) 491 (1999), pp. 123-131.
31. M. Defernez and E.K. Kemsley, The use and misuse of chemometrics for treating classification problems, Trends Anal. Chem. 16 (1997), pp. 216-221.
32. M. Karelson, V.S. Labonov, and A.R. Katritzky, Quantum-chemical descriptors in QSAR/ QSPR studies, Chem. Rev. 96 (1996), p. 1027.
33. G.S. Chen, B.V. Bhagwat, P.Y. Liao, H.T. Chen, S.B. Lin, and C.W. Chern, Specific stabilization of DNA triple helices by indolo[2,1-b]-quinazolin-6,12-dione derivatives, Bioorg. Med. Chem. Lett. 17 (2007), pp. 1769-1772.
34. J.L. Mergny, G. Duval-Valentin, C.H. Nguyen, L. Perrouault, B. Faucon, M. Rougee, T. Montenay-Garestier, E. Bisagni, and C. Helene, Triple helix specific ligands, Science 256 (1992), pp. 1681-1684.